Search - tctmd.com

Displaying 321 - 340 of 505

Sort: Relevancy | Date

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

March 31, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

March 13, 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

February 20, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

January 27, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

TCT-18. Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study

Presentation TCT 2013

TCT-18. Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study

Presenter: Ankit Garg

October 29, 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presentation TCT 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presenter: Sahil Parikh

October 27, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

October 11, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.